National Healthcare Properties, Inc. (HLTC)
OTCMKTS · Delayed Price · Currency is USD
12.00
0.00 (0.00%)
Aug 6, 2025, 4:00 PM EST
HLTC Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 245.7 | 57.62 | 21.65 | 46.41 | 53.65 | 59.74 |
Cash & Short-Term Investments | 245.7 | 57.62 | 21.65 | 46.41 | 53.65 | 59.74 |
Cash Growth | 421.39% | 166.12% | -53.34% | -13.50% | -10.18% | -17.44% |
Accounts Receivable | 7.16 | 9.25 | 5.85 | - | - | - |
Restricted Cash | 56.68 | 50.83 | 52.44 | 44.91 | 22.88 | 25.64 |
Total Current Assets | 309.53 | 117.7 | 79.95 | 91.32 | 76.54 | 85.38 |
Net Property, Plant & Equipment | 1,600 | 1,526 | 1,776 | 1,947 | 1,986 | 2,058 |
Other Long-Term Assets | 66.91 | 67.87 | 89.63 | 106.47 | 117.7 | 71.18 |
Total Assets | 1,976 | 1,712 | 1,946 | 2,145 | 2,180 | 2,214 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 48.25 | 44.38 | 89.58 | 48.36 | 45.25 | 42.71 |
Other Current Liabilities | 2.81 | 3.34 | 3.5 | 3.5 | 3.5 | 3.41 |
Total Current Liabilities | 51.06 | 47.72 | 93.07 | 51.85 | 48.74 | 46.12 |
Long-Term Debt | 848.16 | 1,037 | 1,141 | 809 | 578.7 | 584.24 |
Long-Term Leases | 8.42 | 8.47 | 8.11 | 8.04 | 8.09 | 8.13 |
Other Long-Term Liabilities | 11.42 | 14.29 | 13.34 | 14.67 | 15.33 | 33.47 |
Total Long-Term Liabilities | 867.99 | 1,060 | 1,163 | 831.7 | 602.12 | 625.83 |
Total Liabilities | 919.05 | 1,107 | 1,256 | 1,245 | 1,181 | 1,174 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Preferred Stock | 0.06 | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 |
Common Stock | 1.58 | 1.13 | 1.13 | 1.12 | 1.05 | 0.99 |
Additional Paid-in Capital | 3,001 | 2,531 | 2,534 | 2,509 | 2,417 | 2,330 |
Accumulated Other Comprehensive Income | 4.81 | 5.6 | 16.64 | 23.46 | 36.91 | -14.34 |
Retained Earnings | -1,954 | -1,938 | -1,867 | -1,640 | -1,462 | -1,283 |
Total Common Shareholders' Equity | 1,054 | 600.06 | 684.56 | 894.15 | 992.64 | 1,034 |
Minority Interest | 3.1 | 4.46 | 5.57 | 6.43 | 6.55 | 6.7 |
Shareholders' Equity | 1,057 | 604.53 | 690.13 | 900.58 | 999.19 | 1,040 |
Total Liabilities & Equity | 1,976 | 1,712 | 1,946 | 2,145 | 2,180 | 2,214 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 856.57 | 1,045 | 1,149 | 817.03 | 586.79 | 592.37 |
Net Cash (Debt) | -610.88 | -987.62 | -1,128 | -770.62 | -533.13 | -532.63 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -16.67 | -34.89 | -39.87 | -27.25 | -18.86 | -18.86 |
Book Value | 1,054 | 600.06 | 684.56 | 894.15 | 992.64 | 1,034 |
Book Value Per Share | 28.77 | 21.20 | 24.20 | 31.62 | 35.12 | 36.60 |
Tangible Book Value | 1,054 | 600.06 | 684.56 | 894.15 | 992.64 | 1,034 |
Tangible Book Value Per Share | 28.77 | 21.20 | 24.20 | 31.62 | 35.12 | 36.60 |